Correlation between copy number variations of arm-level result and selected clinical features
Uterine Corpus Endometrioid Carcinoma (Primary solid tumor)
28 January 2016  |  analyses__2016_01_28
Maintainer Information
Citation Information
Maintained by TCGA GDAC Team (Broad Institute/MD Anderson Cancer Center/Harvard Medical School)
Cite as Broad Institute TCGA Genome Data Analysis Center (2016): Correlation between copy number variations of arm-level result and selected clinical features. Broad Institute of MIT and Harvard. doi:10.7908/C12Z1517
Overview
Introduction

This pipeline computes the correlation between significant arm-level copy number variations (cnvs) and selected clinical features.

Summary

Testing the association between copy number variation 82 arm-level events and 4 clinical features across 539 patients, 158 significant findings detected with Q value < 0.25.

  • 1p gain cnv correlated to 'Time to Death',  'HISTOLOGICAL_TYPE', and 'RESIDUAL_TUMOR'.

  • 2p gain cnv correlated to 'Time to Death' and 'HISTOLOGICAL_TYPE'.

  • 2q gain cnv correlated to 'Time to Death' and 'HISTOLOGICAL_TYPE'.

  • 3p gain cnv correlated to 'HISTOLOGICAL_TYPE'.

  • 3q gain cnv correlated to 'Time to Death',  'RADIATION_THERAPY', and 'HISTOLOGICAL_TYPE'.

  • 4p gain cnv correlated to 'Time to Death',  'HISTOLOGICAL_TYPE', and 'RESIDUAL_TUMOR'.

  • 4q gain cnv correlated to 'HISTOLOGICAL_TYPE' and 'RESIDUAL_TUMOR'.

  • 5p gain cnv correlated to 'Time to Death',  'HISTOLOGICAL_TYPE', and 'RESIDUAL_TUMOR'.

  • 5q gain cnv correlated to 'Time to Death' and 'HISTOLOGICAL_TYPE'.

  • 6p gain cnv correlated to 'RADIATION_THERAPY',  'HISTOLOGICAL_TYPE', and 'RESIDUAL_TUMOR'.

  • 6q gain cnv correlated to 'HISTOLOGICAL_TYPE' and 'RESIDUAL_TUMOR'.

  • 7p gain cnv correlated to 'Time to Death' and 'HISTOLOGICAL_TYPE'.

  • 7q gain cnv correlated to 'Time to Death' and 'HISTOLOGICAL_TYPE'.

  • 8p gain cnv correlated to 'Time to Death' and 'RADIATION_THERAPY'.

  • 8q gain cnv correlated to 'Time to Death' and 'HISTOLOGICAL_TYPE'.

  • 9p gain cnv correlated to 'RADIATION_THERAPY' and 'RESIDUAL_TUMOR'.

  • 9q gain cnv correlated to 'RESIDUAL_TUMOR'.

  • 11p gain cnv correlated to 'HISTOLOGICAL_TYPE'.

  • 11q gain cnv correlated to 'Time to Death' and 'HISTOLOGICAL_TYPE'.

  • 12p gain cnv correlated to 'HISTOLOGICAL_TYPE'.

  • 12q gain cnv correlated to 'HISTOLOGICAL_TYPE'.

  • 13q gain cnv correlated to 'RADIATION_THERAPY' and 'HISTOLOGICAL_TYPE'.

  • 14q gain cnv correlated to 'HISTOLOGICAL_TYPE'.

  • 15q gain cnv correlated to 'Time to Death' and 'RESIDUAL_TUMOR'.

  • 16p gain cnv correlated to 'HISTOLOGICAL_TYPE'.

  • 16q gain cnv correlated to 'RESIDUAL_TUMOR'.

  • 17p gain cnv correlated to 'HISTOLOGICAL_TYPE'.

  • 17q gain cnv correlated to 'Time to Death',  'HISTOLOGICAL_TYPE', and 'RESIDUAL_TUMOR'.

  • 18p gain cnv correlated to 'Time to Death',  'HISTOLOGICAL_TYPE', and 'RESIDUAL_TUMOR'.

  • 18q gain cnv correlated to 'Time to Death',  'HISTOLOGICAL_TYPE', and 'RESIDUAL_TUMOR'.

  • 19p gain cnv correlated to 'HISTOLOGICAL_TYPE'.

  • 19q gain cnv correlated to 'Time to Death' and 'HISTOLOGICAL_TYPE'.

  • 20p gain cnv correlated to 'Time to Death',  'HISTOLOGICAL_TYPE', and 'RESIDUAL_TUMOR'.

  • 20q gain cnv correlated to 'Time to Death',  'HISTOLOGICAL_TYPE', and 'RESIDUAL_TUMOR'.

  • 21q gain cnv correlated to 'Time to Death' and 'HISTOLOGICAL_TYPE'.

  • 22q gain cnv correlated to 'Time to Death',  'HISTOLOGICAL_TYPE', and 'RESIDUAL_TUMOR'.

  • xq gain cnv correlated to 'Time to Death'.

  • 1p loss cnv correlated to 'HISTOLOGICAL_TYPE' and 'RESIDUAL_TUMOR'.

  • 1q loss cnv correlated to 'HISTOLOGICAL_TYPE' and 'RESIDUAL_TUMOR'.

  • 2p loss cnv correlated to 'Time to Death'.

  • 2q loss cnv correlated to 'Time to Death'.

  • 3p loss cnv correlated to 'Time to Death' and 'HISTOLOGICAL_TYPE'.

  • 3q loss cnv correlated to 'HISTOLOGICAL_TYPE'.

  • 4p loss cnv correlated to 'Time to Death' and 'HISTOLOGICAL_TYPE'.

  • 4q loss cnv correlated to 'Time to Death' and 'HISTOLOGICAL_TYPE'.

  • 5p loss cnv correlated to 'Time to Death' and 'HISTOLOGICAL_TYPE'.

  • 5q loss cnv correlated to 'Time to Death' and 'HISTOLOGICAL_TYPE'.

  • 6p loss cnv correlated to 'HISTOLOGICAL_TYPE'.

  • 6q loss cnv correlated to 'HISTOLOGICAL_TYPE'.

  • 7p loss cnv correlated to 'Time to Death' and 'HISTOLOGICAL_TYPE'.

  • 7q loss cnv correlated to 'HISTOLOGICAL_TYPE'.

  • 8p loss cnv correlated to 'Time to Death',  'RADIATION_THERAPY', and 'HISTOLOGICAL_TYPE'.

  • 8q loss cnv correlated to 'HISTOLOGICAL_TYPE'.

  • 9p loss cnv correlated to 'Time to Death',  'HISTOLOGICAL_TYPE', and 'RESIDUAL_TUMOR'.

  • 9q loss cnv correlated to 'Time to Death' and 'HISTOLOGICAL_TYPE'.

  • 10p loss cnv correlated to 'Time to Death' and 'HISTOLOGICAL_TYPE'.

  • 10q loss cnv correlated to 'Time to Death' and 'HISTOLOGICAL_TYPE'.

  • 11p loss cnv correlated to 'Time to Death' and 'HISTOLOGICAL_TYPE'.

  • 11q loss cnv correlated to 'Time to Death' and 'HISTOLOGICAL_TYPE'.

  • 12p loss cnv correlated to 'Time to Death',  'HISTOLOGICAL_TYPE', and 'RESIDUAL_TUMOR'.

  • 12q loss cnv correlated to 'Time to Death' and 'HISTOLOGICAL_TYPE'.

  • 13q loss cnv correlated to 'Time to Death' and 'HISTOLOGICAL_TYPE'.

  • 14q loss cnv correlated to 'Time to Death' and 'HISTOLOGICAL_TYPE'.

  • 15q loss cnv correlated to 'Time to Death' and 'HISTOLOGICAL_TYPE'.

  • 16p loss cnv correlated to 'Time to Death',  'HISTOLOGICAL_TYPE', and 'RESIDUAL_TUMOR'.

  • 16q loss cnv correlated to 'Time to Death',  'HISTOLOGICAL_TYPE', and 'RESIDUAL_TUMOR'.

  • 17p loss cnv correlated to 'Time to Death',  'RADIATION_THERAPY',  'HISTOLOGICAL_TYPE', and 'RESIDUAL_TUMOR'.

  • 17q loss cnv correlated to 'Time to Death' and 'HISTOLOGICAL_TYPE'.

  • 18p loss cnv correlated to 'Time to Death',  'HISTOLOGICAL_TYPE', and 'RESIDUAL_TUMOR'.

  • 18q loss cnv correlated to 'HISTOLOGICAL_TYPE' and 'RESIDUAL_TUMOR'.

  • 19p loss cnv correlated to 'Time to Death',  'HISTOLOGICAL_TYPE', and 'RESIDUAL_TUMOR'.

  • 19q loss cnv correlated to 'Time to Death' and 'HISTOLOGICAL_TYPE'.

  • 20p loss cnv correlated to 'HISTOLOGICAL_TYPE'.

  • 20q loss cnv correlated to 'HISTOLOGICAL_TYPE'.

  • 21q loss cnv correlated to 'Time to Death' and 'HISTOLOGICAL_TYPE'.

  • 22q loss cnv correlated to 'Time to Death' and 'HISTOLOGICAL_TYPE'.

  • xp loss cnv correlated to 'Time to Death',  'HISTOLOGICAL_TYPE', and 'RESIDUAL_TUMOR'.

  • xq loss cnv correlated to 'Time to Death',  'HISTOLOGICAL_TYPE', and 'RESIDUAL_TUMOR'.

Results
Overview of the results

Table 1.  Get Full Table Overview of the association between significant copy number variation of 82 arm-level events and 4 clinical features. Shown in the table are P values (Q values). Thresholded by Q value < 0.25, 158 significant findings detected.

Clinical
Features
Time
to
Death
RADIATION
THERAPY
HISTOLOGICAL
TYPE
RESIDUAL
TUMOR
nCNV (%) nWild-Type logrank test Fisher's exact test Fisher's exact test Fisher's exact test
17p loss 129 (24%) 410 4.07e-05
(0.000212)
0.0731
(0.165)
1e-05
(6.31e-05)
0.0847
(0.189)
1p gain 54 (10%) 485 0.0593
(0.142)
0.231
(0.387)
4e-05
(0.000212)
0.092
(0.201)
3q gain 85 (16%) 454 0.000773
(0.00317)
0.00699
(0.0236)
1e-05
(6.31e-05)
0.205
(0.364)
4p gain 14 (3%) 525 0.0247
(0.0674)
0.414
(0.572)
0.00145
(0.00553)
0.1
(0.215)
5p gain 52 (10%) 487 3.18e-07
(6.31e-05)
0.647
(0.775)
1e-05
(6.31e-05)
0.0938
(0.204)
6p gain 81 (15%) 458 0.164
(0.309)
0.0598
(0.142)
1e-05
(6.31e-05)
0.0565
(0.139)
17q gain 30 (6%) 509 0.0125
(0.0392)
0.441
(0.603)
2e-05
(0.000111)
0.0243
(0.067)
18p gain 73 (14%) 466 0.0302
(0.08)
0.798
(0.861)
1e-05
(6.31e-05)
0.019
(0.0548)
18q gain 46 (9%) 493 0.00715
(0.0239)
0.753
(0.839)
1e-05
(6.31e-05)
0.0113
(0.0364)
20p gain 109 (20%) 430 0.000131
(0.000653)
0.738
(0.837)
1e-05
(6.31e-05)
0.0171
(0.0498)
20q gain 130 (24%) 409 1.54e-05
(9.37e-05)
1
(1.00)
1e-05
(6.31e-05)
0.0041
(0.0143)
22q gain 30 (6%) 509 0.117
(0.245)
1
(1.00)
1e-05
(6.31e-05)
0.024
(0.0667)
8p loss 78 (14%) 461 0.0167
(0.0488)
0.015
(0.0453)
1e-05
(6.31e-05)
0.304
(0.456)
9p loss 99 (18%) 440 3.24e-05
(0.000174)
0.908
(0.937)
1e-05
(6.31e-05)
0.0763
(0.171)
12p loss 45 (8%) 494 0.000375
(0.00171)
0.753
(0.839)
1e-05
(6.31e-05)
0.0526
(0.132)
16p loss 99 (18%) 440 9.49e-06
(6.31e-05)
0.728
(0.837)
1e-05
(6.31e-05)
0.0575
(0.14)
16q loss 140 (26%) 399 0.00374
(0.0133)
0.539
(0.68)
1e-05
(6.31e-05)
0.0599
(0.142)
18p loss 51 (9%) 488 0.0679
(0.156)
0.64
(0.774)
0.00034
(0.00157)
0.0663
(0.154)
19p loss 57 (11%) 482 0.00582
(0.0199)
0.765
(0.839)
1e-05
(6.31e-05)
0.0873
(0.192)
xp loss 86 (16%) 453 2.06e-05
(0.000112)
0.808
(0.868)
1e-05
(6.31e-05)
0.0572
(0.14)
xq loss 70 (13%) 469 0.000752
(0.00312)
0.181
(0.332)
1e-05
(6.31e-05)
0.097
(0.209)
2p gain 93 (17%) 446 4.85e-07
(6.31e-05)
0.237
(0.395)
1e-05
(6.31e-05)
0.763
(0.839)
2q gain 78 (14%) 461 6.83e-07
(6.31e-05)
0.127
(0.259)
1e-05
(6.31e-05)
0.377
(0.535)
4q gain 8 (1%) 531 0.434
(0.596)
0.704
(0.814)
0.0272
(0.0731)
0.119
(0.247)
5q gain 20 (4%) 519 0.0128
(0.0395)
0.641
(0.774)
0.00044
(0.00195)
0.251
(0.41)
6q gain 66 (12%) 473 0.166
(0.309)
0.409
(0.569)
2e-05
(0.000111)
0.0226
(0.064)
7p gain 68 (13%) 471 0.0114
(0.0365)
0.893
(0.933)
0.0237
(0.0664)
0.389
(0.544)
7q gain 65 (12%) 474 0.00064
(0.0028)
0.779
(0.849)
0.103
(0.219)
0.502
(0.653)
8p gain 116 (22%) 423 0.0872
(0.192)
0.05
(0.126)
0.758
(0.839)
0.153
(0.299)
8q gain 159 (29%) 380 0.0119
(0.0376)
0.493
(0.648)
0.00395
(0.0139)
0.187
(0.338)
9p gain 22 (4%) 517 0.301
(0.455)
0.108
(0.228)
0.144
(0.284)
0.0494
(0.126)
11q gain 20 (4%) 519 0.0054
(0.0187)
0.255
(0.412)
0.0131
(0.0403)
0.215
(0.372)
13q gain 30 (6%) 509 0.474
(0.634)
0.0354
(0.0921)
1e-05
(6.31e-05)
0.309
(0.461)
15q gain 11 (2%) 528 0.0137
(0.0415)
0.124
(0.254)
0.818
(0.877)
0.0459
(0.118)
19q gain 58 (11%) 481 0.000841
(0.00336)
0.667
(0.788)
1e-05
(6.31e-05)
0.482
(0.639)
21q gain 39 (7%) 500 0.0669
(0.155)
0.228
(0.386)
1e-05
(6.31e-05)
0.25
(0.41)
1p loss 27 (5%) 512 0.287
(0.44)
0.164
(0.309)
1e-05
(6.31e-05)
0.00266
(0.00969)
1q loss 16 (3%) 523 0.21
(0.37)
0.444
(0.604)
0.00066
(0.00285)
0.016
(0.0476)
3p loss 52 (10%) 487 0.0108
(0.035)
0.88
(0.924)
1e-05
(6.31e-05)
0.785
(0.852)
4p loss 106 (20%) 433 0.00202
(0.00744)
0.735
(0.837)
1e-05
(6.31e-05)
0.347
(0.502)
4q loss 104 (19%) 435 0.00013
(0.000653)
0.91
(0.937)
1e-05
(6.31e-05)
0.641
(0.774)
5p loss 53 (10%) 486 0.0214
(0.0609)
0.458
(0.617)
1e-05
(6.31e-05)
0.172
(0.319)
5q loss 73 (14%) 466 0.000238
(0.00115)
0.52
(0.669)
1e-05
(6.31e-05)
0.763
(0.839)
7p loss 45 (8%) 494 0.036
(0.093)
1
(1.00)
1e-05
(6.31e-05)
0.216
(0.372)
9q loss 117 (22%) 422 0.000249
(0.00118)
0.745
(0.839)
1e-05
(6.31e-05)
0.326
(0.478)
10p loss 44 (8%) 495 0.0334
(0.0876)
0.507
(0.658)
1e-05
(6.31e-05)
0.276
(0.429)
10q loss 40 (7%) 499 0.0651
(0.154)
0.496
(0.648)
1e-05
(6.31e-05)
0.642
(0.774)
11p loss 76 (14%) 463 1.48e-05
(9.16e-05)
0.796
(0.861)
1e-05
(6.31e-05)
0.287
(0.44)
11q loss 73 (14%) 466 0.000163
(0.000798)
0.51
(0.658)
1e-05
(6.31e-05)
0.191
(0.345)
12q loss 40 (7%) 499 0.000276
(0.00129)
0.74
(0.837)
1e-05
(6.31e-05)
0.688
(0.797)
13q loss 93 (17%) 446 0.00068
(0.00286)
0.341
(0.495)
1e-05
(6.31e-05)
0.764
(0.839)
14q loss 62 (12%) 477 0.00162
(0.00612)
0.67
(0.788)
1e-05
(6.31e-05)
0.637
(0.774)
15q loss 109 (20%) 430 0.00272
(0.00981)
0.912
(0.937)
1e-05
(6.31e-05)
0.495
(0.648)
17q loss 93 (17%) 446 0.0018
(0.00671)
0.192
(0.345)
1e-05
(6.31e-05)
0.246
(0.407)
18q loss 63 (12%) 476 0.141
(0.283)
0.314
(0.464)
1e-05
(6.31e-05)
0.0723
(0.165)
19q loss 54 (10%) 485 0.0535
(0.133)
0.647
(0.775)
1e-05
(6.31e-05)
0.248
(0.408)
21q loss 54 (10%) 485 0.000828
(0.00335)
1
(1.00)
1e-05
(6.31e-05)
0.262
(0.412)
22q loss 110 (20%) 429 0.000676
(0.00286)
0.91
(0.937)
1e-05
(6.31e-05)
0.203
(0.363)
3p gain 48 (9%) 491 0.373
(0.534)
0.753
(0.839)
0.0004
(0.0018)
0.382
(0.539)
9q gain 10 (2%) 529 0.28
(0.434)
0.476
(0.634)
0.26
(0.412)
0.00752
(0.0249)
11p gain 23 (4%) 516 0.257
(0.412)
0.83
(0.884)
2e-05
(0.000111)
0.181
(0.332)
12p gain 69 (13%) 470 0.935
(0.958)
1
(1.00)
1e-05
(6.31e-05)
0.671
(0.788)
12q gain 51 (9%) 488 0.434
(0.596)
0.654
(0.78)
0.0657
(0.154)
0.532
(0.674)
14q gain 36 (7%) 503 0.256
(0.412)
0.604
(0.754)
2e-05
(0.000111)
0.374
(0.534)
16p gain 25 (5%) 514 0.882
(0.924)
0.674
(0.788)
0.0163
(0.0482)
0.146
(0.288)
16q gain 10 (2%) 529 0.294
(0.448)
0.525
(0.67)
0.262
(0.412)
0.00946
(0.031)
17p gain 13 (2%) 526 0.295
(0.448)
0.771
(0.843)
0.104
(0.22)
0.166
(0.309)
19p gain 55 (10%) 484 0.265
(0.413)
0.556
(0.698)
1e-05
(6.31e-05)
0.642
(0.774)
xq gain 64 (12%) 475 0.0258
(0.07)
0.213
(0.372)
0.305
(0.456)
0.155
(0.302)
2p loss 12 (2%) 527 0.0281
(0.075)
0.124
(0.254)
0.214
(0.372)
0.186
(0.338)
2q loss 18 (3%) 521 0.00123
(0.00482)
0.134
(0.271)
0.143
(0.284)
0.531
(0.674)
3q loss 31 (6%) 508 0.559
(0.699)
0.341
(0.495)
0.00012
(0.000615)
0.351
(0.506)
6p loss 20 (4%) 519 0.737
(0.837)
0.227
(0.386)
2e-05
(0.000111)
0.383
(0.539)
6q loss 25 (5%) 514 0.522
(0.669)
0.674
(0.788)
1e-05
(6.31e-05)
0.314
(0.464)
7q loss 45 (8%) 494 0.16
(0.307)
0.634
(0.774)
1e-05
(6.31e-05)
0.637
(0.774)
8q loss 22 (4%) 517 0.9
(0.937)
0.483
(0.639)
1e-05
(6.31e-05)
0.317
(0.466)
20p loss 22 (4%) 517 0.624
(0.774)
0.261
(0.412)
0.001
(0.00395)
0.162
(0.309)
20q loss 11 (2%) 528 0.822
(0.878)
0.223
(0.381)
0.00135
(0.00521)
0.856
(0.903)
1q gain 189 (35%) 350 0.144
(0.284)
1
(1.00)
0.39
(0.544)
0.947
(0.965)
10p gain 116 (22%) 423 0.946
(0.965)
0.459
(0.617)
0.739
(0.837)
0.848
(0.897)
10q gain 108 (20%) 431 0.675
(0.788)
0.23
(0.386)
0.833
(0.884)
0.217
(0.372)
xp gain 63 (12%) 476 0.259
(0.412)
0.677
(0.788)
0.455
(0.617)
0.158
(0.306)
'1p gain' versus 'Time to Death'

P value = 0.0593 (logrank test), Q value = 0.14

Table S1.  Gene #1: '1p gain' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
1P GAIN MUTATED 54 13 0.1 - 109.1 (24.3)
1P GAIN WILD-TYPE 483 77 0.2 - 225.5 (30.0)

Figure S1.  Get High-res Image Gene #1: '1p gain' versus Clinical Feature #1: 'Time to Death'

'1p gain' versus 'HISTOLOGICAL_TYPE'

P value = 4e-05 (Fisher's exact test), Q value = 0.00021

Table S2.  Gene #1: '1p gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
1P GAIN MUTATED 27 2 25
1P GAIN WILD-TYPE 377 20 88

Figure S2.  Get High-res Image Gene #1: '1p gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'1p gain' versus 'RESIDUAL_TUMOR'

P value = 0.092 (Fisher's exact test), Q value = 0.2

Table S3.  Gene #1: '1p gain' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

nPatients R0 R1 R2 RX
ALL 371 22 16 40
1P GAIN MUTATED 31 1 2 8
1P GAIN WILD-TYPE 340 21 14 32

Figure S3.  Get High-res Image Gene #1: '1p gain' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

'2p gain' versus 'Time to Death'

P value = 4.85e-07 (logrank test), Q value = 6.3e-05

Table S4.  Gene #3: '2p gain' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
2P GAIN MUTATED 92 31 0.1 - 149.6 (23.9)
2P GAIN WILD-TYPE 445 59 0.1 - 225.5 (30.1)

Figure S4.  Get High-res Image Gene #3: '2p gain' versus Clinical Feature #1: 'Time to Death'

'2p gain' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S5.  Gene #3: '2p gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
2P GAIN MUTATED 43 5 45
2P GAIN WILD-TYPE 361 17 68

Figure S5.  Get High-res Image Gene #3: '2p gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'2q gain' versus 'Time to Death'

P value = 6.83e-07 (logrank test), Q value = 6.3e-05

Table S6.  Gene #4: '2q gain' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
2Q GAIN MUTATED 77 26 0.1 - 110.1 (23.3)
2Q GAIN WILD-TYPE 460 64 0.1 - 225.5 (30.6)

Figure S6.  Get High-res Image Gene #4: '2q gain' versus Clinical Feature #1: 'Time to Death'

'2q gain' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S7.  Gene #4: '2q gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
2Q GAIN MUTATED 37 4 37
2Q GAIN WILD-TYPE 367 18 76

Figure S7.  Get High-res Image Gene #4: '2q gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'3p gain' versus 'HISTOLOGICAL_TYPE'

P value = 4e-04 (Fisher's exact test), Q value = 0.0018

Table S8.  Gene #5: '3p gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
3P GAIN MUTATED 27 0 21
3P GAIN WILD-TYPE 377 22 92

Figure S8.  Get High-res Image Gene #5: '3p gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'3q gain' versus 'Time to Death'

P value = 0.000773 (logrank test), Q value = 0.0032

Table S9.  Gene #6: '3q gain' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
3Q GAIN MUTATED 85 25 0.1 - 225.5 (27.4)
3Q GAIN WILD-TYPE 452 65 0.2 - 185.8 (30.0)

Figure S9.  Get High-res Image Gene #6: '3q gain' versus Clinical Feature #1: 'Time to Death'

'3q gain' versus 'RADIATION_THERAPY'

P value = 0.00699 (Fisher's exact test), Q value = 0.024

Table S10.  Gene #6: '3q gain' versus Clinical Feature #2: 'RADIATION_THERAPY'

nPatients NO YES
ALL 290 224
3Q GAIN MUTATED 34 46
3Q GAIN WILD-TYPE 256 178

Figure S10.  Get High-res Image Gene #6: '3q gain' versus Clinical Feature #2: 'RADIATION_THERAPY'

'3q gain' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S11.  Gene #6: '3q gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
3Q GAIN MUTATED 37 4 44
3Q GAIN WILD-TYPE 367 18 69

Figure S11.  Get High-res Image Gene #6: '3q gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'4p gain' versus 'Time to Death'

P value = 0.0247 (logrank test), Q value = 0.067

Table S12.  Gene #7: '4p gain' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
4P GAIN MUTATED 14 5 5.9 - 97.7 (22.3)
4P GAIN WILD-TYPE 523 85 0.1 - 225.5 (29.9)

Figure S12.  Get High-res Image Gene #7: '4p gain' versus Clinical Feature #1: 'Time to Death'

'4p gain' versus 'HISTOLOGICAL_TYPE'

P value = 0.00145 (Fisher's exact test), Q value = 0.0055

Table S13.  Gene #7: '4p gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
4P GAIN MUTATED 5 0 9
4P GAIN WILD-TYPE 399 22 104

Figure S13.  Get High-res Image Gene #7: '4p gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'4p gain' versus 'RESIDUAL_TUMOR'

P value = 0.1 (Fisher's exact test), Q value = 0.22

Table S14.  Gene #7: '4p gain' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

nPatients R0 R1 R2 RX
ALL 371 22 16 40
4P GAIN MUTATED 10 1 2 0
4P GAIN WILD-TYPE 361 21 14 40

Figure S14.  Get High-res Image Gene #7: '4p gain' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

'4q gain' versus 'HISTOLOGICAL_TYPE'

P value = 0.0272 (Fisher's exact test), Q value = 0.073

Table S15.  Gene #8: '4q gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
4Q GAIN MUTATED 3 0 5
4Q GAIN WILD-TYPE 401 22 108

Figure S15.  Get High-res Image Gene #8: '4q gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'4q gain' versus 'RESIDUAL_TUMOR'

P value = 0.119 (Fisher's exact test), Q value = 0.25

Table S16.  Gene #8: '4q gain' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

nPatients R0 R1 R2 RX
ALL 371 22 16 40
4Q GAIN MUTATED 4 1 1 0
4Q GAIN WILD-TYPE 367 21 15 40

Figure S16.  Get High-res Image Gene #8: '4q gain' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

'5p gain' versus 'Time to Death'

P value = 3.18e-07 (logrank test), Q value = 6.3e-05

Table S17.  Gene #9: '5p gain' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
5P GAIN MUTATED 52 20 0.4 - 110.1 (22.9)
5P GAIN WILD-TYPE 485 70 0.1 - 225.5 (30.1)

Figure S17.  Get High-res Image Gene #9: '5p gain' versus Clinical Feature #1: 'Time to Death'

'5p gain' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S18.  Gene #9: '5p gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
5P GAIN MUTATED 16 3 33
5P GAIN WILD-TYPE 388 19 80

Figure S18.  Get High-res Image Gene #9: '5p gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'5p gain' versus 'RESIDUAL_TUMOR'

P value = 0.0938 (Fisher's exact test), Q value = 0.2

Table S19.  Gene #9: '5p gain' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

nPatients R0 R1 R2 RX
ALL 371 22 16 40
5P GAIN MUTATED 37 2 5 4
5P GAIN WILD-TYPE 334 20 11 36

Figure S19.  Get High-res Image Gene #9: '5p gain' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

'5q gain' versus 'Time to Death'

P value = 0.0128 (logrank test), Q value = 0.04

Table S20.  Gene #10: '5q gain' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
5Q GAIN MUTATED 20 7 1.4 - 79.1 (27.9)
5Q GAIN WILD-TYPE 517 83 0.1 - 225.5 (29.9)

Figure S20.  Get High-res Image Gene #10: '5q gain' versus Clinical Feature #1: 'Time to Death'

'5q gain' versus 'HISTOLOGICAL_TYPE'

P value = 0.00044 (Fisher's exact test), Q value = 0.002

Table S21.  Gene #10: '5q gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
5Q GAIN MUTATED 8 0 12
5Q GAIN WILD-TYPE 396 22 101

Figure S21.  Get High-res Image Gene #10: '5q gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'6p gain' versus 'RADIATION_THERAPY'

P value = 0.0598 (Fisher's exact test), Q value = 0.14

Table S22.  Gene #11: '6p gain' versus Clinical Feature #2: 'RADIATION_THERAPY'

nPatients NO YES
ALL 290 224
6P GAIN MUTATED 35 41
6P GAIN WILD-TYPE 255 183

Figure S22.  Get High-res Image Gene #11: '6p gain' versus Clinical Feature #2: 'RADIATION_THERAPY'

'6p gain' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S23.  Gene #11: '6p gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
6P GAIN MUTATED 40 1 40
6P GAIN WILD-TYPE 364 21 73

Figure S23.  Get High-res Image Gene #11: '6p gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'6p gain' versus 'RESIDUAL_TUMOR'

P value = 0.0565 (Fisher's exact test), Q value = 0.14

Table S24.  Gene #11: '6p gain' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

nPatients R0 R1 R2 RX
ALL 371 22 16 40
6P GAIN MUTATED 46 2 3 11
6P GAIN WILD-TYPE 325 20 13 29

Figure S24.  Get High-res Image Gene #11: '6p gain' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

'6q gain' versus 'HISTOLOGICAL_TYPE'

P value = 2e-05 (Fisher's exact test), Q value = 0.00011

Table S25.  Gene #12: '6q gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
6Q GAIN MUTATED 35 1 30
6Q GAIN WILD-TYPE 369 21 83

Figure S25.  Get High-res Image Gene #12: '6q gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'6q gain' versus 'RESIDUAL_TUMOR'

P value = 0.0226 (Fisher's exact test), Q value = 0.064

Table S26.  Gene #12: '6q gain' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

nPatients R0 R1 R2 RX
ALL 371 22 16 40
6Q GAIN MUTATED 37 1 3 10
6Q GAIN WILD-TYPE 334 21 13 30

Figure S26.  Get High-res Image Gene #12: '6q gain' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

'7p gain' versus 'Time to Death'

P value = 0.0114 (logrank test), Q value = 0.036

Table S27.  Gene #13: '7p gain' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
7P GAIN MUTATED 67 17 0.2 - 125.4 (21.9)
7P GAIN WILD-TYPE 470 73 0.1 - 225.5 (30.3)

Figure S27.  Get High-res Image Gene #13: '7p gain' versus Clinical Feature #1: 'Time to Death'

'7p gain' versus 'HISTOLOGICAL_TYPE'

P value = 0.0237 (Fisher's exact test), Q value = 0.066

Table S28.  Gene #13: '7p gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
7P GAIN MUTATED 42 4 22
7P GAIN WILD-TYPE 362 18 91

Figure S28.  Get High-res Image Gene #13: '7p gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'7q gain' versus 'Time to Death'

P value = 0.00064 (logrank test), Q value = 0.0028

Table S29.  Gene #14: '7q gain' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
7Q GAIN MUTATED 64 18 0.2 - 125.4 (20.2)
7Q GAIN WILD-TYPE 473 72 0.1 - 225.5 (30.7)

Figure S29.  Get High-res Image Gene #14: '7q gain' versus Clinical Feature #1: 'Time to Death'

'7q gain' versus 'HISTOLOGICAL_TYPE'

P value = 0.103 (Fisher's exact test), Q value = 0.22

Table S30.  Gene #14: '7q gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
7Q GAIN MUTATED 42 4 19
7Q GAIN WILD-TYPE 362 18 94

Figure S30.  Get High-res Image Gene #14: '7q gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'8p gain' versus 'Time to Death'

P value = 0.0872 (logrank test), Q value = 0.19

Table S31.  Gene #15: '8p gain' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
8P GAIN MUTATED 115 25 0.1 - 225.5 (31.1)
8P GAIN WILD-TYPE 422 65 0.1 - 185.8 (29.8)

Figure S31.  Get High-res Image Gene #15: '8p gain' versus Clinical Feature #1: 'Time to Death'

'8p gain' versus 'RADIATION_THERAPY'

P value = 0.05 (Fisher's exact test), Q value = 0.13

Table S32.  Gene #15: '8p gain' versus Clinical Feature #2: 'RADIATION_THERAPY'

nPatients NO YES
ALL 290 224
8P GAIN MUTATED 70 38
8P GAIN WILD-TYPE 220 186

Figure S32.  Get High-res Image Gene #15: '8p gain' versus Clinical Feature #2: 'RADIATION_THERAPY'

'8q gain' versus 'Time to Death'

P value = 0.0119 (logrank test), Q value = 0.038

Table S33.  Gene #16: '8q gain' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
8Q GAIN MUTATED 157 37 0.1 - 225.5 (30.1)
8Q GAIN WILD-TYPE 380 53 0.2 - 185.8 (29.8)

Figure S33.  Get High-res Image Gene #16: '8q gain' versus Clinical Feature #1: 'Time to Death'

'8q gain' versus 'HISTOLOGICAL_TYPE'

P value = 0.00395 (Fisher's exact test), Q value = 0.014

Table S34.  Gene #16: '8q gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
8Q GAIN MUTATED 104 8 47
8Q GAIN WILD-TYPE 300 14 66

Figure S34.  Get High-res Image Gene #16: '8q gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'9p gain' versus 'RADIATION_THERAPY'

P value = 0.108 (Fisher's exact test), Q value = 0.23

Table S35.  Gene #17: '9p gain' versus Clinical Feature #2: 'RADIATION_THERAPY'

nPatients NO YES
ALL 290 224
9P GAIN MUTATED 15 5
9P GAIN WILD-TYPE 275 219

Figure S35.  Get High-res Image Gene #17: '9p gain' versus Clinical Feature #2: 'RADIATION_THERAPY'

'9p gain' versus 'RESIDUAL_TUMOR'

P value = 0.0494 (Fisher's exact test), Q value = 0.13

Table S36.  Gene #17: '9p gain' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

nPatients R0 R1 R2 RX
ALL 371 22 16 40
9P GAIN MUTATED 12 2 2 3
9P GAIN WILD-TYPE 359 20 14 37

Figure S36.  Get High-res Image Gene #17: '9p gain' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

'9q gain' versus 'RESIDUAL_TUMOR'

P value = 0.00752 (Fisher's exact test), Q value = 0.025

Table S37.  Gene #18: '9q gain' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

nPatients R0 R1 R2 RX
ALL 371 22 16 40
9Q GAIN MUTATED 3 1 1 3
9Q GAIN WILD-TYPE 368 21 15 37

Figure S37.  Get High-res Image Gene #18: '9q gain' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

'11p gain' versus 'HISTOLOGICAL_TYPE'

P value = 2e-05 (Fisher's exact test), Q value = 0.00011

Table S38.  Gene #21: '11p gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
11P GAIN MUTATED 8 0 15
11P GAIN WILD-TYPE 396 22 98

Figure S38.  Get High-res Image Gene #21: '11p gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'11q gain' versus 'Time to Death'

P value = 0.0054 (logrank test), Q value = 0.019

Table S39.  Gene #22: '11q gain' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
11Q GAIN MUTATED 20 8 2.1 - 92.9 (30.5)
11Q GAIN WILD-TYPE 517 82 0.1 - 225.5 (29.9)

Figure S39.  Get High-res Image Gene #22: '11q gain' versus Clinical Feature #1: 'Time to Death'

'11q gain' versus 'HISTOLOGICAL_TYPE'

P value = 0.0131 (Fisher's exact test), Q value = 0.04

Table S40.  Gene #22: '11q gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
11Q GAIN MUTATED 10 0 10
11Q GAIN WILD-TYPE 394 22 103

Figure S40.  Get High-res Image Gene #22: '11q gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'12p gain' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S41.  Gene #23: '12p gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
12P GAIN MUTATED 35 3 31
12P GAIN WILD-TYPE 369 19 82

Figure S41.  Get High-res Image Gene #23: '12p gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'12q gain' versus 'HISTOLOGICAL_TYPE'

P value = 0.0657 (Fisher's exact test), Q value = 0.15

Table S42.  Gene #24: '12q gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
12Q GAIN MUTATED 32 2 17
12Q GAIN WILD-TYPE 372 20 96

Figure S42.  Get High-res Image Gene #24: '12q gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'13q gain' versus 'RADIATION_THERAPY'

P value = 0.0354 (Fisher's exact test), Q value = 0.092

Table S43.  Gene #25: '13q gain' versus Clinical Feature #2: 'RADIATION_THERAPY'

nPatients NO YES
ALL 290 224
13Q GAIN MUTATED 11 19
13Q GAIN WILD-TYPE 279 205

Figure S43.  Get High-res Image Gene #25: '13q gain' versus Clinical Feature #2: 'RADIATION_THERAPY'

'13q gain' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S44.  Gene #25: '13q gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
13Q GAIN MUTATED 8 1 21
13Q GAIN WILD-TYPE 396 21 92

Figure S44.  Get High-res Image Gene #25: '13q gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'14q gain' versus 'HISTOLOGICAL_TYPE'

P value = 2e-05 (Fisher's exact test), Q value = 0.00011

Table S45.  Gene #26: '14q gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
14Q GAIN MUTATED 15 2 19
14Q GAIN WILD-TYPE 389 20 94

Figure S45.  Get High-res Image Gene #26: '14q gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'15q gain' versus 'Time to Death'

P value = 0.0137 (logrank test), Q value = 0.042

Table S46.  Gene #27: '15q gain' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
15Q GAIN MUTATED 11 4 4.4 - 75.7 (20.8)
15Q GAIN WILD-TYPE 526 86 0.1 - 225.5 (30.0)

Figure S46.  Get High-res Image Gene #27: '15q gain' versus Clinical Feature #1: 'Time to Death'

'15q gain' versus 'RESIDUAL_TUMOR'

P value = 0.0459 (Fisher's exact test), Q value = 0.12

Table S47.  Gene #27: '15q gain' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

nPatients R0 R1 R2 RX
ALL 371 22 16 40
15Q GAIN MUTATED 4 1 1 2
15Q GAIN WILD-TYPE 367 21 15 38

Figure S47.  Get High-res Image Gene #27: '15q gain' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

'16p gain' versus 'HISTOLOGICAL_TYPE'

P value = 0.0163 (Fisher's exact test), Q value = 0.048

Table S48.  Gene #28: '16p gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
16P GAIN MUTATED 13 1 11
16P GAIN WILD-TYPE 391 21 102

Figure S48.  Get High-res Image Gene #28: '16p gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'16q gain' versus 'RESIDUAL_TUMOR'

P value = 0.00946 (Fisher's exact test), Q value = 0.031

Table S49.  Gene #29: '16q gain' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

nPatients R0 R1 R2 RX
ALL 371 22 16 40
16Q GAIN MUTATED 4 3 0 1
16Q GAIN WILD-TYPE 367 19 16 39

Figure S49.  Get High-res Image Gene #29: '16q gain' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

'17p gain' versus 'HISTOLOGICAL_TYPE'

P value = 0.104 (Fisher's exact test), Q value = 0.22

Table S50.  Gene #30: '17p gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
17P GAIN MUTATED 7 0 6
17P GAIN WILD-TYPE 397 22 107

Figure S50.  Get High-res Image Gene #30: '17p gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'17q gain' versus 'Time to Death'

P value = 0.0125 (logrank test), Q value = 0.039

Table S51.  Gene #31: '17q gain' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
17Q GAIN MUTATED 30 8 0.1 - 78.4 (20.4)
17Q GAIN WILD-TYPE 507 82 0.1 - 225.5 (30.4)

Figure S51.  Get High-res Image Gene #31: '17q gain' versus Clinical Feature #1: 'Time to Death'

'17q gain' versus 'HISTOLOGICAL_TYPE'

P value = 2e-05 (Fisher's exact test), Q value = 0.00011

Table S52.  Gene #31: '17q gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
17Q GAIN MUTATED 12 0 18
17Q GAIN WILD-TYPE 392 22 95

Figure S52.  Get High-res Image Gene #31: '17q gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'17q gain' versus 'RESIDUAL_TUMOR'

P value = 0.0243 (Fisher's exact test), Q value = 0.067

Table S53.  Gene #31: '17q gain' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

nPatients R0 R1 R2 RX
ALL 371 22 16 40
17Q GAIN MUTATED 18 1 4 3
17Q GAIN WILD-TYPE 353 21 12 37

Figure S53.  Get High-res Image Gene #31: '17q gain' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

'18p gain' versus 'Time to Death'

P value = 0.0302 (logrank test), Q value = 0.08

Table S54.  Gene #32: '18p gain' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
18P GAIN MUTATED 73 20 0.4 - 125.4 (33.3)
18P GAIN WILD-TYPE 464 70 0.1 - 225.5 (29.4)

Figure S54.  Get High-res Image Gene #32: '18p gain' versus Clinical Feature #1: 'Time to Death'

'18p gain' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S55.  Gene #32: '18p gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
18P GAIN MUTATED 22 5 46
18P GAIN WILD-TYPE 382 17 67

Figure S55.  Get High-res Image Gene #32: '18p gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'18p gain' versus 'RESIDUAL_TUMOR'

P value = 0.019 (Fisher's exact test), Q value = 0.055

Table S56.  Gene #32: '18p gain' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

nPatients R0 R1 R2 RX
ALL 371 22 16 40
18P GAIN MUTATED 47 1 6 8
18P GAIN WILD-TYPE 324 21 10 32

Figure S56.  Get High-res Image Gene #32: '18p gain' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

'18q gain' versus 'Time to Death'

P value = 0.00715 (logrank test), Q value = 0.024

Table S57.  Gene #33: '18q gain' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
18Q GAIN MUTATED 46 15 3.0 - 125.4 (28.5)
18Q GAIN WILD-TYPE 491 75 0.1 - 225.5 (29.9)

Figure S57.  Get High-res Image Gene #33: '18q gain' versus Clinical Feature #1: 'Time to Death'

'18q gain' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S58.  Gene #33: '18q gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
18Q GAIN MUTATED 17 4 25
18Q GAIN WILD-TYPE 387 18 88

Figure S58.  Get High-res Image Gene #33: '18q gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'18q gain' versus 'RESIDUAL_TUMOR'

P value = 0.0113 (Fisher's exact test), Q value = 0.036

Table S59.  Gene #33: '18q gain' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

nPatients R0 R1 R2 RX
ALL 371 22 16 40
18Q GAIN MUTATED 28 0 3 8
18Q GAIN WILD-TYPE 343 22 13 32

Figure S59.  Get High-res Image Gene #33: '18q gain' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

'19p gain' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S60.  Gene #34: '19p gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
19P GAIN MUTATED 21 3 31
19P GAIN WILD-TYPE 383 19 82

Figure S60.  Get High-res Image Gene #34: '19p gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'19q gain' versus 'Time to Death'

P value = 0.000841 (logrank test), Q value = 0.0034

Table S61.  Gene #35: '19q gain' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
19Q GAIN MUTATED 57 18 0.1 - 110.1 (25.5)
19Q GAIN WILD-TYPE 480 72 0.2 - 225.5 (30.1)

Figure S61.  Get High-res Image Gene #35: '19q gain' versus Clinical Feature #1: 'Time to Death'

'19q gain' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S62.  Gene #35: '19q gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
19Q GAIN MUTATED 16 3 39
19Q GAIN WILD-TYPE 388 19 74

Figure S62.  Get High-res Image Gene #35: '19q gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'20p gain' versus 'Time to Death'

P value = 0.000131 (logrank test), Q value = 0.00065

Table S63.  Gene #36: '20p gain' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
20P GAIN MUTATED 109 30 0.1 - 136.6 (27.0)
20P GAIN WILD-TYPE 428 60 0.1 - 225.5 (30.7)

Figure S63.  Get High-res Image Gene #36: '20p gain' versus Clinical Feature #1: 'Time to Death'

'20p gain' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S64.  Gene #36: '20p gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
20P GAIN MUTATED 47 3 59
20P GAIN WILD-TYPE 357 19 54

Figure S64.  Get High-res Image Gene #36: '20p gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'20p gain' versus 'RESIDUAL_TUMOR'

P value = 0.0171 (Fisher's exact test), Q value = 0.05

Table S65.  Gene #36: '20p gain' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

nPatients R0 R1 R2 RX
ALL 371 22 16 40
20P GAIN MUTATED 63 4 7 12
20P GAIN WILD-TYPE 308 18 9 28

Figure S65.  Get High-res Image Gene #36: '20p gain' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

'20q gain' versus 'Time to Death'

P value = 1.54e-05 (logrank test), Q value = 9.4e-05

Table S66.  Gene #37: '20q gain' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
20Q GAIN MUTATED 129 37 0.1 - 225.5 (27.1)
20Q GAIN WILD-TYPE 408 53 0.1 - 185.8 (30.7)

Figure S66.  Get High-res Image Gene #37: '20q gain' versus Clinical Feature #1: 'Time to Death'

'20q gain' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S67.  Gene #37: '20q gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
20Q GAIN MUTATED 58 3 69
20Q GAIN WILD-TYPE 346 19 44

Figure S67.  Get High-res Image Gene #37: '20q gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'20q gain' versus 'RESIDUAL_TUMOR'

P value = 0.0041 (Fisher's exact test), Q value = 0.014

Table S68.  Gene #37: '20q gain' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

nPatients R0 R1 R2 RX
ALL 371 22 16 40
20Q GAIN MUTATED 74 5 9 13
20Q GAIN WILD-TYPE 297 17 7 27

Figure S68.  Get High-res Image Gene #37: '20q gain' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

'21q gain' versus 'Time to Death'

P value = 0.0669 (logrank test), Q value = 0.15

Table S69.  Gene #38: '21q gain' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
21Q GAIN MUTATED 39 10 0.1 - 110.1 (25.5)
21Q GAIN WILD-TYPE 498 80 0.1 - 225.5 (30.1)

Figure S69.  Get High-res Image Gene #38: '21q gain' versus Clinical Feature #1: 'Time to Death'

'21q gain' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S70.  Gene #38: '21q gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
21Q GAIN MUTATED 13 1 25
21Q GAIN WILD-TYPE 391 21 88

Figure S70.  Get High-res Image Gene #38: '21q gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'22q gain' versus 'Time to Death'

P value = 0.117 (logrank test), Q value = 0.25

Table S71.  Gene #39: '22q gain' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
22Q GAIN MUTATED 29 8 0.4 - 225.5 (27.9)
22Q GAIN WILD-TYPE 508 82 0.1 - 185.8 (30.1)

Figure S71.  Get High-res Image Gene #39: '22q gain' versus Clinical Feature #1: 'Time to Death'

'22q gain' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S72.  Gene #39: '22q gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
22Q GAIN MUTATED 7 1 22
22Q GAIN WILD-TYPE 397 21 91

Figure S72.  Get High-res Image Gene #39: '22q gain' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'22q gain' versus 'RESIDUAL_TUMOR'

P value = 0.024 (Fisher's exact test), Q value = 0.067

Table S73.  Gene #39: '22q gain' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

nPatients R0 R1 R2 RX
ALL 371 22 16 40
22Q GAIN MUTATED 18 1 4 3
22Q GAIN WILD-TYPE 353 21 12 37

Figure S73.  Get High-res Image Gene #39: '22q gain' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

'xq gain' versus 'Time to Death'

P value = 0.0258 (logrank test), Q value = 0.07

Table S74.  Gene #41: 'xq gain' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
XQ GAIN MUTATED 64 16 0.1 - 83.6 (26.4)
XQ GAIN WILD-TYPE 473 74 0.2 - 225.5 (30.0)

Figure S74.  Get High-res Image Gene #41: 'xq gain' versus Clinical Feature #1: 'Time to Death'

'1p loss' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S75.  Gene #42: '1p loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
1P LOSS MUTATED 7 3 17
1P LOSS WILD-TYPE 397 19 96

Figure S75.  Get High-res Image Gene #42: '1p loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'1p loss' versus 'RESIDUAL_TUMOR'

P value = 0.00266 (Fisher's exact test), Q value = 0.0097

Table S76.  Gene #42: '1p loss' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

nPatients R0 R1 R2 RX
ALL 371 22 16 40
1P LOSS MUTATED 17 3 4 0
1P LOSS WILD-TYPE 354 19 12 40

Figure S76.  Get High-res Image Gene #42: '1p loss' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

'1q loss' versus 'HISTOLOGICAL_TYPE'

P value = 0.00066 (Fisher's exact test), Q value = 0.0028

Table S77.  Gene #43: '1q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
1Q LOSS MUTATED 5 2 9
1Q LOSS WILD-TYPE 399 20 104

Figure S77.  Get High-res Image Gene #43: '1q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'1q loss' versus 'RESIDUAL_TUMOR'

P value = 0.016 (Fisher's exact test), Q value = 0.048

Table S78.  Gene #43: '1q loss' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

nPatients R0 R1 R2 RX
ALL 371 22 16 40
1Q LOSS MUTATED 10 1 3 0
1Q LOSS WILD-TYPE 361 21 13 40

Figure S78.  Get High-res Image Gene #43: '1q loss' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

'2p loss' versus 'Time to Death'

P value = 0.0281 (logrank test), Q value = 0.075

Table S79.  Gene #44: '2p loss' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
2P LOSS MUTATED 12 4 0.6 - 92.9 (18.9)
2P LOSS WILD-TYPE 525 86 0.1 - 225.5 (29.9)

Figure S79.  Get High-res Image Gene #44: '2p loss' versus Clinical Feature #1: 'Time to Death'

'2q loss' versus 'Time to Death'

P value = 0.00123 (logrank test), Q value = 0.0048

Table S80.  Gene #45: '2q loss' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
2Q LOSS MUTATED 18 7 0.6 - 92.9 (21.4)
2Q LOSS WILD-TYPE 519 83 0.1 - 225.5 (30.0)

Figure S80.  Get High-res Image Gene #45: '2q loss' versus Clinical Feature #1: 'Time to Death'

'3p loss' versus 'Time to Death'

P value = 0.0108 (logrank test), Q value = 0.035

Table S81.  Gene #46: '3p loss' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
3P LOSS MUTATED 52 14 0.1 - 125.4 (24.9)
3P LOSS WILD-TYPE 485 76 0.1 - 225.5 (30.4)

Figure S81.  Get High-res Image Gene #46: '3p loss' versus Clinical Feature #1: 'Time to Death'

'3p loss' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S82.  Gene #46: '3p loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
3P LOSS MUTATED 20 6 26
3P LOSS WILD-TYPE 384 16 87

Figure S82.  Get High-res Image Gene #46: '3p loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'3q loss' versus 'HISTOLOGICAL_TYPE'

P value = 0.00012 (Fisher's exact test), Q value = 0.00061

Table S83.  Gene #47: '3q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
3Q LOSS MUTATED 13 2 16
3Q LOSS WILD-TYPE 391 20 97

Figure S83.  Get High-res Image Gene #47: '3q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'4p loss' versus 'Time to Death'

P value = 0.00202 (logrank test), Q value = 0.0074

Table S84.  Gene #48: '4p loss' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
4P LOSS MUTATED 105 28 0.2 - 149.6 (27.2)
4P LOSS WILD-TYPE 432 62 0.1 - 225.5 (30.7)

Figure S84.  Get High-res Image Gene #48: '4p loss' versus Clinical Feature #1: 'Time to Death'

'4p loss' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S85.  Gene #48: '4p loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
4P LOSS MUTATED 34 8 64
4P LOSS WILD-TYPE 370 14 49

Figure S85.  Get High-res Image Gene #48: '4p loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'4q loss' versus 'Time to Death'

P value = 0.00013 (logrank test), Q value = 0.00065

Table S86.  Gene #49: '4q loss' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
4Q LOSS MUTATED 103 30 0.2 - 149.6 (27.9)
4Q LOSS WILD-TYPE 434 60 0.1 - 225.5 (30.1)

Figure S86.  Get High-res Image Gene #49: '4q loss' versus Clinical Feature #1: 'Time to Death'

'4q loss' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S87.  Gene #49: '4q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
4Q LOSS MUTATED 33 8 63
4Q LOSS WILD-TYPE 371 14 50

Figure S87.  Get High-res Image Gene #49: '4q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'5p loss' versus 'Time to Death'

P value = 0.0214 (logrank test), Q value = 0.061

Table S88.  Gene #50: '5p loss' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
5P LOSS MUTATED 53 15 0.2 - 149.6 (27.1)
5P LOSS WILD-TYPE 484 75 0.1 - 225.5 (30.1)

Figure S88.  Get High-res Image Gene #50: '5p loss' versus Clinical Feature #1: 'Time to Death'

'5p loss' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S89.  Gene #50: '5p loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
5P LOSS MUTATED 17 1 35
5P LOSS WILD-TYPE 387 21 78

Figure S89.  Get High-res Image Gene #50: '5p loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'5q loss' versus 'Time to Death'

P value = 0.000238 (logrank test), Q value = 0.0011

Table S90.  Gene #51: '5q loss' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
5Q LOSS MUTATED 73 23 0.2 - 149.6 (27.2)
5Q LOSS WILD-TYPE 464 67 0.1 - 225.5 (30.1)

Figure S90.  Get High-res Image Gene #51: '5q loss' versus Clinical Feature #1: 'Time to Death'

'5q loss' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S91.  Gene #51: '5q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
5Q LOSS MUTATED 20 4 49
5Q LOSS WILD-TYPE 384 18 64

Figure S91.  Get High-res Image Gene #51: '5q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'6p loss' versus 'HISTOLOGICAL_TYPE'

P value = 2e-05 (Fisher's exact test), Q value = 0.00011

Table S92.  Gene #52: '6p loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
6P LOSS MUTATED 5 2 13
6P LOSS WILD-TYPE 399 20 100

Figure S92.  Get High-res Image Gene #52: '6p loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'6q loss' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S93.  Gene #53: '6q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
6Q LOSS MUTATED 5 1 19
6Q LOSS WILD-TYPE 399 21 94

Figure S93.  Get High-res Image Gene #53: '6q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'7p loss' versus 'Time to Death'

P value = 0.036 (logrank test), Q value = 0.093

Table S94.  Gene #54: '7p loss' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
7P LOSS MUTATED 45 13 2.1 - 110.1 (30.7)
7P LOSS WILD-TYPE 492 77 0.1 - 225.5 (29.8)

Figure S94.  Get High-res Image Gene #54: '7p loss' versus Clinical Feature #1: 'Time to Death'

'7p loss' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S95.  Gene #54: '7p loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
7P LOSS MUTATED 15 2 28
7P LOSS WILD-TYPE 389 20 85

Figure S95.  Get High-res Image Gene #54: '7p loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'7q loss' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S96.  Gene #55: '7q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
7Q LOSS MUTATED 10 2 33
7Q LOSS WILD-TYPE 394 20 80

Figure S96.  Get High-res Image Gene #55: '7q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'8p loss' versus 'Time to Death'

P value = 0.0167 (logrank test), Q value = 0.049

Table S97.  Gene #56: '8p loss' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
8P LOSS MUTATED 78 20 0.4 - 110.1 (27.6)
8P LOSS WILD-TYPE 459 70 0.1 - 225.5 (30.1)

Figure S97.  Get High-res Image Gene #56: '8p loss' versus Clinical Feature #1: 'Time to Death'

'8p loss' versus 'RADIATION_THERAPY'

P value = 0.015 (Fisher's exact test), Q value = 0.045

Table S98.  Gene #56: '8p loss' versus Clinical Feature #2: 'RADIATION_THERAPY'

nPatients NO YES
ALL 290 224
8P LOSS MUTATED 31 41
8P LOSS WILD-TYPE 259 183

Figure S98.  Get High-res Image Gene #56: '8p loss' versus Clinical Feature #2: 'RADIATION_THERAPY'

'8p loss' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S99.  Gene #56: '8p loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
8P LOSS MUTATED 17 4 57
8P LOSS WILD-TYPE 387 18 56

Figure S99.  Get High-res Image Gene #56: '8p loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'8q loss' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S100.  Gene #57: '8q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
8Q LOSS MUTATED 1 1 20
8Q LOSS WILD-TYPE 403 21 93

Figure S100.  Get High-res Image Gene #57: '8q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'9p loss' versus 'Time to Death'

P value = 3.24e-05 (logrank test), Q value = 0.00017

Table S101.  Gene #58: '9p loss' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
9P LOSS MUTATED 99 32 0.3 - 149.6 (27.1)
9P LOSS WILD-TYPE 438 58 0.1 - 225.5 (30.3)

Figure S101.  Get High-res Image Gene #58: '9p loss' versus Clinical Feature #1: 'Time to Death'

'9p loss' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S102.  Gene #58: '9p loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
9P LOSS MUTATED 34 7 58
9P LOSS WILD-TYPE 370 15 55

Figure S102.  Get High-res Image Gene #58: '9p loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'9p loss' versus 'RESIDUAL_TUMOR'

P value = 0.0763 (Fisher's exact test), Q value = 0.17

Table S103.  Gene #58: '9p loss' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

nPatients R0 R1 R2 RX
ALL 371 22 16 40
9P LOSS MUTATED 60 5 6 10
9P LOSS WILD-TYPE 311 17 10 30

Figure S103.  Get High-res Image Gene #58: '9p loss' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

'9q loss' versus 'Time to Death'

P value = 0.000249 (logrank test), Q value = 0.0012

Table S104.  Gene #59: '9q loss' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
9Q LOSS MUTATED 117 34 0.2 - 136.6 (27.9)
9Q LOSS WILD-TYPE 420 56 0.1 - 225.5 (30.1)

Figure S104.  Get High-res Image Gene #59: '9q loss' versus Clinical Feature #1: 'Time to Death'

'9q loss' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S105.  Gene #59: '9q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
9Q LOSS MUTATED 45 9 63
9Q LOSS WILD-TYPE 359 13 50

Figure S105.  Get High-res Image Gene #59: '9q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'10p loss' versus 'Time to Death'

P value = 0.0334 (logrank test), Q value = 0.088

Table S106.  Gene #60: '10p loss' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
10P LOSS MUTATED 44 12 0.3 - 125.4 (23.9)
10P LOSS WILD-TYPE 493 78 0.1 - 225.5 (30.1)

Figure S106.  Get High-res Image Gene #60: '10p loss' versus Clinical Feature #1: 'Time to Death'

'10p loss' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S107.  Gene #60: '10p loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
10P LOSS MUTATED 9 5 30
10P LOSS WILD-TYPE 395 17 83

Figure S107.  Get High-res Image Gene #60: '10p loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'10q loss' versus 'Time to Death'

P value = 0.0651 (logrank test), Q value = 0.15

Table S108.  Gene #61: '10q loss' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
10Q LOSS MUTATED 40 11 0.3 - 125.4 (26.6)
10Q LOSS WILD-TYPE 497 79 0.1 - 225.5 (30.1)

Figure S108.  Get High-res Image Gene #61: '10q loss' versus Clinical Feature #1: 'Time to Death'

'10q loss' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S109.  Gene #61: '10q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
10Q LOSS MUTATED 12 5 23
10Q LOSS WILD-TYPE 392 17 90

Figure S109.  Get High-res Image Gene #61: '10q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'11p loss' versus 'Time to Death'

P value = 1.48e-05 (logrank test), Q value = 9.2e-05

Table S110.  Gene #62: '11p loss' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
11P LOSS MUTATED 76 25 0.3 - 136.6 (25.5)
11P LOSS WILD-TYPE 461 65 0.1 - 225.5 (30.1)

Figure S110.  Get High-res Image Gene #62: '11p loss' versus Clinical Feature #1: 'Time to Death'

'11p loss' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S111.  Gene #62: '11p loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
11P LOSS MUTATED 28 7 41
11P LOSS WILD-TYPE 376 15 72

Figure S111.  Get High-res Image Gene #62: '11p loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'11q loss' versus 'Time to Death'

P value = 0.000163 (logrank test), Q value = 8e-04

Table S112.  Gene #63: '11q loss' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
11Q LOSS MUTATED 73 22 0.3 - 136.6 (22.6)
11Q LOSS WILD-TYPE 464 68 0.1 - 225.5 (30.7)

Figure S112.  Get High-res Image Gene #63: '11q loss' versus Clinical Feature #1: 'Time to Death'

'11q loss' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S113.  Gene #63: '11q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
11Q LOSS MUTATED 24 7 42
11Q LOSS WILD-TYPE 380 15 71

Figure S113.  Get High-res Image Gene #63: '11q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'12p loss' versus 'Time to Death'

P value = 0.000375 (logrank test), Q value = 0.0017

Table S114.  Gene #64: '12p loss' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
12P LOSS MUTATED 45 16 8.2 - 118.2 (27.0)
12P LOSS WILD-TYPE 492 74 0.1 - 225.5 (30.3)

Figure S114.  Get High-res Image Gene #64: '12p loss' versus Clinical Feature #1: 'Time to Death'

'12p loss' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S115.  Gene #64: '12p loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
12P LOSS MUTATED 15 1 29
12P LOSS WILD-TYPE 389 21 84

Figure S115.  Get High-res Image Gene #64: '12p loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'12p loss' versus 'RESIDUAL_TUMOR'

P value = 0.0526 (Fisher's exact test), Q value = 0.13

Table S116.  Gene #64: '12p loss' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

nPatients R0 R1 R2 RX
ALL 371 22 16 40
12P LOSS MUTATED 28 3 4 5
12P LOSS WILD-TYPE 343 19 12 35

Figure S116.  Get High-res Image Gene #64: '12p loss' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

'12q loss' versus 'Time to Death'

P value = 0.000276 (logrank test), Q value = 0.0013

Table S117.  Gene #65: '12q loss' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
12Q LOSS MUTATED 40 14 8.2 - 118.2 (26.0)
12Q LOSS WILD-TYPE 497 76 0.1 - 225.5 (30.4)

Figure S117.  Get High-res Image Gene #65: '12q loss' versus Clinical Feature #1: 'Time to Death'

'12q loss' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S118.  Gene #65: '12q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
12Q LOSS MUTATED 10 2 28
12Q LOSS WILD-TYPE 394 20 85

Figure S118.  Get High-res Image Gene #65: '12q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'13q loss' versus 'Time to Death'

P value = 0.00068 (logrank test), Q value = 0.0029

Table S119.  Gene #66: '13q loss' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
13Q LOSS MUTATED 92 25 0.3 - 149.6 (25.7)
13Q LOSS WILD-TYPE 445 65 0.1 - 225.5 (30.7)

Figure S119.  Get High-res Image Gene #66: '13q loss' versus Clinical Feature #1: 'Time to Death'

'13q loss' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S120.  Gene #66: '13q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
13Q LOSS MUTATED 48 6 39
13Q LOSS WILD-TYPE 356 16 74

Figure S120.  Get High-res Image Gene #66: '13q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'14q loss' versus 'Time to Death'

P value = 0.00162 (logrank test), Q value = 0.0061

Table S121.  Gene #67: '14q loss' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
14Q LOSS MUTATED 62 18 0.3 - 125.4 (27.6)
14Q LOSS WILD-TYPE 475 72 0.1 - 225.5 (30.1)

Figure S121.  Get High-res Image Gene #67: '14q loss' versus Clinical Feature #1: 'Time to Death'

'14q loss' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S122.  Gene #67: '14q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
14Q LOSS MUTATED 20 3 39
14Q LOSS WILD-TYPE 384 19 74

Figure S122.  Get High-res Image Gene #67: '14q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'15q loss' versus 'Time to Death'

P value = 0.00272 (logrank test), Q value = 0.0098

Table S123.  Gene #68: '15q loss' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
15Q LOSS MUTATED 109 28 0.2 - 136.6 (24.1)
15Q LOSS WILD-TYPE 428 62 0.1 - 225.5 (31.9)

Figure S123.  Get High-res Image Gene #68: '15q loss' versus Clinical Feature #1: 'Time to Death'

'15q loss' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S124.  Gene #68: '15q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
15Q LOSS MUTATED 37 9 63
15Q LOSS WILD-TYPE 367 13 50

Figure S124.  Get High-res Image Gene #68: '15q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'16p loss' versus 'Time to Death'

P value = 9.49e-06 (logrank test), Q value = 6.3e-05

Table S125.  Gene #69: '16p loss' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
16P LOSS MUTATED 98 30 0.2 - 110.1 (27.6)
16P LOSS WILD-TYPE 439 60 0.1 - 225.5 (30.7)

Figure S125.  Get High-res Image Gene #69: '16p loss' versus Clinical Feature #1: 'Time to Death'

'16p loss' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S126.  Gene #69: '16p loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
16P LOSS MUTATED 35 6 58
16P LOSS WILD-TYPE 369 16 55

Figure S126.  Get High-res Image Gene #69: '16p loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'16p loss' versus 'RESIDUAL_TUMOR'

P value = 0.0575 (Fisher's exact test), Q value = 0.14

Table S127.  Gene #69: '16p loss' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

nPatients R0 R1 R2 RX
ALL 371 22 16 40
16P LOSS MUTATED 58 5 6 10
16P LOSS WILD-TYPE 313 17 10 30

Figure S127.  Get High-res Image Gene #69: '16p loss' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

'16q loss' versus 'Time to Death'

P value = 0.00374 (logrank test), Q value = 0.013

Table S128.  Gene #70: '16q loss' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
16Q LOSS MUTATED 139 34 0.1 - 123.7 (28.6)
16Q LOSS WILD-TYPE 398 56 0.1 - 225.5 (30.6)

Figure S128.  Get High-res Image Gene #70: '16q loss' versus Clinical Feature #1: 'Time to Death'

'16q loss' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S129.  Gene #70: '16q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
16Q LOSS MUTATED 57 7 76
16Q LOSS WILD-TYPE 347 15 37

Figure S129.  Get High-res Image Gene #70: '16q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'16q loss' versus 'RESIDUAL_TUMOR'

P value = 0.0599 (Fisher's exact test), Q value = 0.14

Table S130.  Gene #70: '16q loss' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

nPatients R0 R1 R2 RX
ALL 371 22 16 40
16Q LOSS MUTATED 83 8 7 13
16Q LOSS WILD-TYPE 288 14 9 27

Figure S130.  Get High-res Image Gene #70: '16q loss' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

'17p loss' versus 'Time to Death'

P value = 4.07e-05 (logrank test), Q value = 0.00021

Table S131.  Gene #71: '17p loss' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
17P LOSS MUTATED 128 37 0.2 - 136.6 (27.9)
17P LOSS WILD-TYPE 409 53 0.1 - 225.5 (30.1)

Figure S131.  Get High-res Image Gene #71: '17p loss' versus Clinical Feature #1: 'Time to Death'

'17p loss' versus 'RADIATION_THERAPY'

P value = 0.0731 (Fisher's exact test), Q value = 0.17

Table S132.  Gene #71: '17p loss' versus Clinical Feature #2: 'RADIATION_THERAPY'

nPatients NO YES
ALL 290 224
17P LOSS MUTATED 58 60
17P LOSS WILD-TYPE 232 164

Figure S132.  Get High-res Image Gene #71: '17p loss' versus Clinical Feature #2: 'RADIATION_THERAPY'

'17p loss' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S133.  Gene #71: '17p loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
17P LOSS MUTATED 47 10 72
17P LOSS WILD-TYPE 357 12 41

Figure S133.  Get High-res Image Gene #71: '17p loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'17p loss' versus 'RESIDUAL_TUMOR'

P value = 0.0847 (Fisher's exact test), Q value = 0.19

Table S134.  Gene #71: '17p loss' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

nPatients R0 R1 R2 RX
ALL 371 22 16 40
17P LOSS MUTATED 80 8 6 13
17P LOSS WILD-TYPE 291 14 10 27

Figure S134.  Get High-res Image Gene #71: '17p loss' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

'17q loss' versus 'Time to Death'

P value = 0.0018 (logrank test), Q value = 0.0067

Table S135.  Gene #72: '17q loss' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
17Q LOSS MUTATED 92 27 0.2 - 136.6 (29.2)
17Q LOSS WILD-TYPE 445 63 0.1 - 225.5 (30.0)

Figure S135.  Get High-res Image Gene #72: '17q loss' versus Clinical Feature #1: 'Time to Death'

'17q loss' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S136.  Gene #72: '17q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
17Q LOSS MUTATED 39 8 46
17Q LOSS WILD-TYPE 365 14 67

Figure S136.  Get High-res Image Gene #72: '17q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'18p loss' versus 'Time to Death'

P value = 0.0679 (logrank test), Q value = 0.16

Table S137.  Gene #73: '18p loss' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
18P LOSS MUTATED 50 12 0.1 - 136.6 (22.8)
18P LOSS WILD-TYPE 487 78 0.1 - 225.5 (30.4)

Figure S137.  Get High-res Image Gene #73: '18p loss' versus Clinical Feature #1: 'Time to Death'

'18p loss' versus 'HISTOLOGICAL_TYPE'

P value = 0.00034 (Fisher's exact test), Q value = 0.0016

Table S138.  Gene #73: '18p loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
18P LOSS MUTATED 26 5 20
18P LOSS WILD-TYPE 378 17 93

Figure S138.  Get High-res Image Gene #73: '18p loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'18p loss' versus 'RESIDUAL_TUMOR'

P value = 0.0663 (Fisher's exact test), Q value = 0.15

Table S139.  Gene #73: '18p loss' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

nPatients R0 R1 R2 RX
ALL 371 22 16 40
18P LOSS MUTATED 30 5 1 6
18P LOSS WILD-TYPE 341 17 15 34

Figure S139.  Get High-res Image Gene #73: '18p loss' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

'18q loss' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S140.  Gene #74: '18q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
18Q LOSS MUTATED 29 6 28
18Q LOSS WILD-TYPE 375 16 85

Figure S140.  Get High-res Image Gene #74: '18q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'18q loss' versus 'RESIDUAL_TUMOR'

P value = 0.0723 (Fisher's exact test), Q value = 0.16

Table S141.  Gene #74: '18q loss' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

nPatients R0 R1 R2 RX
ALL 371 22 16 40
18Q LOSS MUTATED 37 5 3 7
18Q LOSS WILD-TYPE 334 17 13 33

Figure S141.  Get High-res Image Gene #74: '18q loss' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

'19p loss' versus 'Time to Death'

P value = 0.00582 (logrank test), Q value = 0.02

Table S142.  Gene #75: '19p loss' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
19P LOSS MUTATED 57 16 0.2 - 136.6 (25.5)
19P LOSS WILD-TYPE 480 74 0.1 - 225.5 (30.1)

Figure S142.  Get High-res Image Gene #75: '19p loss' versus Clinical Feature #1: 'Time to Death'

'19p loss' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S143.  Gene #75: '19p loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
19P LOSS MUTATED 18 4 35
19P LOSS WILD-TYPE 386 18 78

Figure S143.  Get High-res Image Gene #75: '19p loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'19p loss' versus 'RESIDUAL_TUMOR'

P value = 0.0873 (Fisher's exact test), Q value = 0.19

Table S144.  Gene #75: '19p loss' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

nPatients R0 R1 R2 RX
ALL 371 22 16 40
19P LOSS MUTATED 33 4 4 4
19P LOSS WILD-TYPE 338 18 12 36

Figure S144.  Get High-res Image Gene #75: '19p loss' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

'19q loss' versus 'Time to Death'

P value = 0.0535 (logrank test), Q value = 0.13

Table S145.  Gene #76: '19q loss' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
19Q LOSS MUTATED 54 14 0.2 - 136.6 (24.7)
19Q LOSS WILD-TYPE 483 76 0.1 - 225.5 (30.1)

Figure S145.  Get High-res Image Gene #76: '19q loss' versus Clinical Feature #1: 'Time to Death'

'19q loss' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S146.  Gene #76: '19q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
19Q LOSS MUTATED 18 4 32
19Q LOSS WILD-TYPE 386 18 81

Figure S146.  Get High-res Image Gene #76: '19q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'20p loss' versus 'HISTOLOGICAL_TYPE'

P value = 0.001 (Fisher's exact test), Q value = 0.004

Table S147.  Gene #77: '20p loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
20P LOSS MUTATED 9 1 12
20P LOSS WILD-TYPE 395 21 101

Figure S147.  Get High-res Image Gene #77: '20p loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'20q loss' versus 'HISTOLOGICAL_TYPE'

P value = 0.00135 (Fisher's exact test), Q value = 0.0052

Table S148.  Gene #78: '20q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
20Q LOSS MUTATED 3 2 6
20Q LOSS WILD-TYPE 401 20 107

Figure S148.  Get High-res Image Gene #78: '20q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'21q loss' versus 'Time to Death'

P value = 0.000828 (logrank test), Q value = 0.0034

Table S149.  Gene #79: '21q loss' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
21Q LOSS MUTATED 54 17 0.3 - 125.4 (22.9)
21Q LOSS WILD-TYPE 483 73 0.1 - 225.5 (30.1)

Figure S149.  Get High-res Image Gene #79: '21q loss' versus Clinical Feature #1: 'Time to Death'

'21q loss' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S150.  Gene #79: '21q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
21Q LOSS MUTATED 20 4 30
21Q LOSS WILD-TYPE 384 18 83

Figure S150.  Get High-res Image Gene #79: '21q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'22q loss' versus 'Time to Death'

P value = 0.000676 (logrank test), Q value = 0.0029

Table S151.  Gene #80: '22q loss' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
22Q LOSS MUTATED 109 29 0.1 - 136.6 (27.1)
22Q LOSS WILD-TYPE 428 61 0.1 - 225.5 (30.3)

Figure S151.  Get High-res Image Gene #80: '22q loss' versus Clinical Feature #1: 'Time to Death'

'22q loss' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S152.  Gene #80: '22q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
22Q LOSS MUTATED 47 10 53
22Q LOSS WILD-TYPE 357 12 60

Figure S152.  Get High-res Image Gene #80: '22q loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'xp loss' versus 'Time to Death'

P value = 2.06e-05 (logrank test), Q value = 0.00011

Table S153.  Gene #81: 'xp loss' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
XP LOSS MUTATED 85 28 0.3 - 118.2 (27.3)
XP LOSS WILD-TYPE 452 62 0.1 - 225.5 (30.6)

Figure S153.  Get High-res Image Gene #81: 'xp loss' versus Clinical Feature #1: 'Time to Death'

'xp loss' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S154.  Gene #81: 'xp loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
XP LOSS MUTATED 34 5 47
XP LOSS WILD-TYPE 370 17 66

Figure S154.  Get High-res Image Gene #81: 'xp loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'xp loss' versus 'RESIDUAL_TUMOR'

P value = 0.0572 (Fisher's exact test), Q value = 0.14

Table S155.  Gene #81: 'xp loss' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

nPatients R0 R1 R2 RX
ALL 371 22 16 40
XP LOSS MUTATED 55 2 6 9
XP LOSS WILD-TYPE 316 20 10 31

Figure S155.  Get High-res Image Gene #81: 'xp loss' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

'xq loss' versus 'Time to Death'

P value = 0.000752 (logrank test), Q value = 0.0031

Table S156.  Gene #82: 'xq loss' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 537 90 0.1 - 225.5 (29.9)
XQ LOSS MUTATED 69 22 0.3 - 118.2 (28.9)
XQ LOSS WILD-TYPE 468 68 0.1 - 225.5 (30.0)

Figure S156.  Get High-res Image Gene #82: 'xq loss' versus Clinical Feature #1: 'Time to Death'

'xq loss' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 6.3e-05

Table S157.  Gene #82: 'xq loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA MIXED SEROUS AND ENDOMETRIOID SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL 404 22 113
XQ LOSS MUTATED 31 4 35
XQ LOSS WILD-TYPE 373 18 78

Figure S157.  Get High-res Image Gene #82: 'xq loss' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'xq loss' versus 'RESIDUAL_TUMOR'

P value = 0.097 (Fisher's exact test), Q value = 0.21

Table S158.  Gene #82: 'xq loss' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

nPatients R0 R1 R2 RX
ALL 371 22 16 40
XQ LOSS MUTATED 43 2 5 7
XQ LOSS WILD-TYPE 328 20 11 33

Figure S158.  Get High-res Image Gene #82: 'xq loss' versus Clinical Feature #4: 'RESIDUAL_TUMOR'

Methods & Data
Input
  • Copy number data file = broad_values_by_arm.txt from GISTIC pipeline

  • Processed Copy number data file = /xchip/cga/gdac-prod/tcga-gdac/jobResults/GDAC_Correlate_Genomic_Events_Preprocess/UCEC-TP/22534123/transformed.cor.cli.txt

  • Clinical data file = /xchip/cga/gdac-prod/tcga-gdac/jobResults/Append_Data/UCEC-TP/22507145/UCEC-TP.merged_data.txt

  • Number of patients = 539

  • Number of significantly arm-level cnvs = 82

  • Number of selected clinical features = 4

  • Exclude regions that fewer than K tumors have mutations, K = 3

Survival analysis

For survival clinical features, the Kaplan-Meier survival curves of tumors with and without gene mutations were plotted and the statistical significance P values were estimated by logrank test (Bland and Altman 2004) using the 'survdiff' function in R

Fisher's exact test

For binary or multi-class clinical features (nominal or ordinal), two-tailed Fisher's exact tests (Fisher 1922) were used to estimate the P values using the 'fisher.test' function in R

Q value calculation

For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.

Download Results

In addition to the links below, the full results of the analysis summarized in this report can also be downloaded programmatically using firehose_get, or interactively from either the Broad GDAC website or TCGA Data Coordination Center Portal.

References
[1] Bland and Altman, Statistics notes: The logrank test, BMJ 328(7447):1073 (2004)
[2] Fisher, R.A., On the interpretation of chi-square from contingency tables, and the calculation of P, Journal of the Royal Statistical Society 85(1):87-94 (1922)
[3] Benjamini and Hochberg, Controlling the false discovery rate: a practical and powerful approach to multiple testing, Journal of the Royal Statistical Society Series B 59:289-300 (1995)